In addition to proposed uses for low-dose naltrexone that have been studied in clinical research, low-dose naltrexone advocates make unproven claims of its efficacy in treating other conditions, including: various types of cancer, Alzheimer's disease , HIV/AIDS , rheumatoid arthritis , and others. Steven Novella of the Yale University School of Medicine disputed these claims as unsupported by rigorous clinical research, calling many applications pseudoscientific . He further argues that the claim that low-dose naltrexone as an effective treatment for both immune dysfunction and autoimmune diseases is contradictory [ citation needed ] , and that improving the immune system could make the autoimmune disease worse. 
The C-View 2D image is the world’s first and only synthesized 2D image that is FDA approved to replace FFDM within a combined tomosynthesis screening exam. C–View software’s 2D image is designed to be different. Our advanced algorithm takes high-quality tomosynthesis data and instantly generates 2D images designed to enhance details such as bright spots and linear structures while minimizing tissue overlap. This helps to guide and expedite the tomosynthesis exam review . With any new imaging change, training is critical. Several educational options are available to help you become experienced or acquainted with this unique Low Dose 3D™ Mammogram.